Emerging Weight Loss Drugs and What Pharmacies Need to Know Pharmacy Mentor PDF] Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial. Semantic Scholar Incretin hormone agonists: Current and emerging pharmacotherapy for obesity management Alhomoud 2024 Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy Wiley Online Library Combined use of semaglutide with an investigational monoclonal antibody called bimagrumab produced significant fat mass loss while preserving lean mass, results from the phase 2b BELIEVE study found. http: ms.spr.ly 6180SLSUq GLP 1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review ScienceDirect Development of a Long Acting and Stapled Dual Amylin and Calcitonin Receptor Agonist as Monotherapy and Combination with GLP 1R Agonists for the Treatment of Obesity Bioconjugate Chemistry